














• Having hepatitis B or hepatitis C 
• Having cirrhosis 
• Having metabolic syndrome 
• Having liver injury that is long-
lasting 
• Having hemochromatosis 




Cancer Factsheet Liver  
 Key facts 
 
Age profile at diagnosis and death 
Top risk factors 















Median age group=65-69 Median age group=70-74 
 Females Males Total 
Number of new cases per year 83.0 202 285 
     Incidence rate (cases per 100,000 per year) 2.9 8.1 - 
     Cumulative lifetime risk of diagnosis (to age 74) 1 in 478 1 in 156 - 
     Percentage of all invasive cancers * 0.8% 1.7% 1.3% 
     Ranking among most common cancers * 19th 14th 18th 
Number of deaths per year 118 172 290 
     Mortality rate (deaths per 100,000 per year) 4.0 7.4 - 
     Cumulative lifetime risk of death (to age 74) 1 in 400 1 in 192 - 
     Percentage of all cancer deaths 3% 4% 3% 
     Ranking among most common invasive cancer deaths 9th 7th 8th 
Number of people with this cancer still alive, end 2015# 149 396 545 
     Number alive per 100,000 7.0 17.0 12.0 
*invasive only, excluding non-melanoma skin cancer 
# diagnosed since 1994 
Annual average number of cases, 2005-2015: 
colours indicate higher or lower than 
expected based on national rates 
  
Information on cancer mortality provided by the Central 
Statistics Office. Incidence: 2015-2017 estimated averages 
and mortality: 2012-2014 averages. Last updated May 2018 © National Cancer Registry, Ireland 
APC# Incidence: Males (94-15) 6.2%; Females (94-15) 4.8% 
Mortality: Males (94-09) 10.6%; (09-15) 3.7%; Females (94-06) 10.7%,     
(06-15) 2.5% 
# Annual Percentage Change 
Treatment within 1 year 5 year net survival 


























































































Incidence Female Incidence Male
Mortality Female Mortality Male
 






Percent of all cases diagnosed
Male Female
58% pathologically diagnosed 
% of all cases diagnosed 2013-2015 





1994-1998 4.5% 2.5-6.5% 
1999-2003 11.0% 8.2-13.8% 
2004-2008 12.0% 9.6-14.4% 
2009-2013 17.0% 14.0-20.1% 
 
*10 year net survival (hybrid analysis): 
 10.6% (7.7-13.5%) 
Liver 
